The extent of tau lesions in these individuals followed Braak tau stages with minimal subcortical involvements, suggesting that Alzheimer’s disease rather than 4RT or 3RT pathologies underlay FTD manifestations. The gene discussed is MAPT; the disease is Alzheimer disease.